PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23612742-7	2013	Consistent with its anti-apoptotic target BCL2, miR-205 promoted apoptosis in prostate cancer cells in response to DNA damage by cisplatin and doxorubicin in the prostate cancer cell lines PC3 and LnCap.	Cisplatin	129-138	BCL2 apoptosis regulator	Homo sapiens	42-46	
23612742-7	2013	Consistent with its anti-apoptotic target BCL2, miR-205 promoted apoptosis in prostate cancer cells in response to DNA damage by cisplatin and doxorubicin in the prostate cancer cell lines PC3 and LnCap.	Cisplatin	129-138	microRNA 205	Homo sapiens	48-55	
23612742-7	2013	Consistent with its anti-apoptotic target BCL2, miR-205 promoted apoptosis in prostate cancer cells in response to DNA damage by cisplatin and doxorubicin in the prostate cancer cell lines PC3 and LnCap.	Doxorubicin	143-154	BCL2 apoptosis regulator	Homo sapiens	42-46	
23612742-7	2013	Consistent with its anti-apoptotic target BCL2, miR-205 promoted apoptosis in prostate cancer cells in response to DNA damage by cisplatin and doxorubicin in the prostate cancer cell lines PC3 and LnCap.	Doxorubicin	143-154	microRNA 205	Homo sapiens	48-55